Frailty is independently associated with a higher risk and frequency of developing LRTIs among older adults in residential care.
Gram‑negative bloodstream infections are associated with significant morbidity and mortality, making timely pathogen ...
Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the ...
Savara is transitioning from a single-asset biotech to a rare disease commercial infrastructure. Click here to read more on ...
Predictive Health Intelligence today announced a promising new way to identify people with serious liver disease earlier ...
The findings come from the LiveWell study, with results being presented at a major European liver congress this week. The ...
Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO-a certified algorithm de ...
Sanofi India's AccelRare tool swiftly identifies over 300 rare diseases, enhancing early diagnosis and treatment accuracy for ...
Sleep breathing disorders (SBDs)—including obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation syndromes—represent a major yet under-recognised contributor to global ...
Zurich (Switzerland), May 25, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today highlights ...
The Department of Agrarian Reform (DAR) has introduced climate-smart, information-driven farming technologies to 5 agrarian ...
Genome-wide association studies have linked thousands of genetic variants to disease, yet most remain disconnected from drug-relevant biology. Neville Sanjana, Professor at New York University and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results